Recommend to a friend

This module on biliary tract cancer (BTC) aims to enhance clinical practice by addressing diagnostic and therapeutic challenges associated with these rare and aggressive malignancies. The program will cover BTC identification and management, with a focus on the role of the MDM2 and p53 pathway in disease progression. Participants will evaluate the limitations of standard treatment therapies and discuss novel treatment strategies. Through case studies and interactive discussions, learners will apply their knowledge to real-life scenarios, improving their ability to manage BTC effectively and enhance patient outcomes.